New Edge Advisors, LLC Alector, Inc. Transaction History
New Edge Advisors, LLC
- $18.3 Billion
- Q2 2025
A detailed history of New Edge Advisors, LLC transactions in Alector, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 32 shares of ALEC stock, worth $96. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32
Previous 32
-0.0%
Holding current value
$96
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ALEC
# of Institutions
141Shares Held
54.6MCall Options Held
29.8KPut Options Held
13.4K-
Black Rock Inc. New York, NY9.1MShares$27.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.99MShares$18.1 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.88MShares$14.7 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.17MShares$6.55 Million0.01% of portfolio
-
Eversept Partners, LP New York, NY1.99MShares$6 Million0.28% of portfolio
About Alector, Inc.
- Ticker ALEC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 82,563,904
- Market Cap $249M
- Description
- Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...